130 related articles for article (PubMed ID: 32445434)
1. Antibacterial prophylaxis of febrile neutropenia is not effective in the pre-engraftment period in pediatric allogeneic hematopoietic stem cell transplantation.
Ricci E; Mesini A; Bandettini R; Faraci M; Castagnola E
Transpl Infect Dis; 2020 Oct; 22(5):e13340. PubMed ID: 32445434
[No Abstract] [Full Text] [Related]
2. Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting.
Kaya AH; Tekgündüz E; Duygu F; Koca D; Bekdemir F; Batgi H; Ulu Uncu B; Yiğenoğlu TN; Dal MS; Çakar Kızıl M; Altuntaş F
Balkan Med J; 2017 Apr; 34(2):132-139. PubMed ID: 28418340
[TBL] [Abstract][Full Text] [Related]
3. Piperacillin-tazobactam vs. imipenem-cilastatin as empirical therapy in hematopoietic stem cell transplantation recipients with febrile neutropenia.
Jing Y; Li J; Yuan L; Zhao X; Wang Q; Yu L; Zhou D; Huang W
Clin Transplant; 2016 Mar; 30(3):263-9. PubMed ID: 26701371
[TBL] [Abstract][Full Text] [Related]
4. Management of bacteremia in patients undergoing hematopoietic stem cell transplantation.
Castagnola E; Faraci M
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):607-21. PubMed ID: 19485800
[TBL] [Abstract][Full Text] [Related]
5. Gut diversity and the resistome as biomarkers of febrile neutropenia outcome in paediatric oncology patients undergoing hematopoietic stem cell transplantation.
Sardzikova S; Andrijkova K; Svec P; Beke G; Klucar L; Minarik G; Bielik V; Kolenova A; Soltys K
Sci Rep; 2024 Mar; 14(1):5504. PubMed ID: 38448687
[TBL] [Abstract][Full Text] [Related]
6. Viridans Group Streptococci in Pediatric Leukemia and Stem Cell Transplant: Review of a Risk-stratified Guideline for Empiric Vancomycin in Febrile Neutropenia.
Ruhayel SD; Foley DA; Hamilton K; Ferguson P; Kotecha RS; Bowen AC; Yeoh DK
Pediatr Infect Dis J; 2021 Sep; 40(9):832-834. PubMed ID: 34285167
[TBL] [Abstract][Full Text] [Related]
7. De-Escalation and Discontinuation of Empirical Antibiotic Treatment in a Cohort of Allogeneic Hematopoietic Stem Cell Transplantation Recipients during the Pre-Engraftment Period.
Gustinetti G; Raiola AM; Varaldo R; Galaverna F; Gualandi F; Del Bono V; Bacigalupo A; Angelucci E; Viscoli C; Mikulska M
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1721-1726. PubMed ID: 29578073
[TBL] [Abstract][Full Text] [Related]
8. Adverse effects of antibiotics in children with cancer: are short-course antibiotics for febrile neutropenia part of the solution?
Butters C; Thursky K; Hanna DT; Cole T; Davidson A; Buttery J; Haeusler G
Expert Rev Anti Infect Ther; 2023 Mar; 21(3):267-279. PubMed ID: 36694289
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin.
Petteys MM; Kachur E; Pillinger KE; He J; Copelan EA; Shahid Z
J Oncol Pharm Pract; 2020 Apr; 26(3):632-640. PubMed ID: 31423947
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study.
Yeshurun M; Vaxman I; Shargian L; Yahav D; Bishara J; Pasvolsky O; Wolach O; Lahav M; Gurion R; Magen H; Vidal L; Herscovici C; Peck A; Moshe M; Sela-Navon M; Naparstek E; Raanani P; Rozovski U
Clin Microbiol Infect; 2018 Jul; 24(7):749-754. PubMed ID: 29208561
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.
Ziegler M; Landsburg D; Pegues D; Bilker W; Gilmar C; Kucharczuk C; Gorman T; Bink K; Moore A; Fitzpatrick R; Stadtmauer EA; Mangan P; Kraus K; Han JH
Biol Blood Marrow Transplant; 2019 May; 25(5):1004-1010. PubMed ID: 30481595
[TBL] [Abstract][Full Text] [Related]
12. Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update.
Lehrnbecher T; Robinson PD; Ammann RA; Fisher B; Patel P; Phillips R; Beauchemin MP; Carlesse F; Castagnola E; Davis BL; Elgarten CW; Groll AH; Haeusler GM; Koenig C; Santolaya ME; Tissing WJE; Wolf J; Alexander S; Hu H; Dupuis LL; Sung L
J Clin Oncol; 2023 Mar; 41(9):1774-1785. PubMed ID: 36689694
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic levofloxacin in pediatric neutropenic patients during autologous hematopoietic stem cell transplantation.
Hafez HA; Yousif D; Abbassi M; Elborai Y; Elhaddad A
Clin Transplant; 2015 Dec; 29(12):1112-8. PubMed ID: 26363413
[TBL] [Abstract][Full Text] [Related]
14. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
Signorelli J; Zimmer A; Liewer S; Shostrom VK; Freifeld A
Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022
[TBL] [Abstract][Full Text] [Related]
15. Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease.
Parta M; Cuellar-Rodriguez J; Gea-Banacloche J; Qin J; Kelly C; Zerbe CS; Holland SM; Malech HL; Kang EM
Transpl Infect Dis; 2022 Apr; 24(2):e13815. PubMed ID: 35191140
[TBL] [Abstract][Full Text] [Related]
16. Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients.
Rönkkö R; Juutilainen A; Koivula I; Vänskä M; Nousiainen T; Jantunen E; Hämäläinen S
Infect Dis (Lond); 2018 Jun; 50(6):436-442. PubMed ID: 29303041
[TBL] [Abstract][Full Text] [Related]
17. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.
Lehrnbecher T; Robinson P; Fisher B; Alexander S; Ammann RA; Beauchemin M; Carlesse F; Groll AH; Haeusler GM; Santolaya M; Steinbach WJ; Castagnola E; Davis BL; Dupuis LL; Gaur AH; Tissing WJE; Zaoutis T; Phillips R; Sung L
J Clin Oncol; 2017 Jun; 35(18):2082-2094. PubMed ID: 28459614
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia.
Boztug H; Mühlegger N; Pötschger U; Attarbaschi A; Peters C; Mann G; Dworzak M
Ann Hematol; 2017 Jan; 96(1):99-106. PubMed ID: 27699447
[TBL] [Abstract][Full Text] [Related]
19. Adherence to practice guidelines for the management of febrile neutropenia in patients undergoing hematopoietic stem cell transplantation: An observational study in a referral center in Iran.
Ekhtiari Kolour SR; Shahrami B; Kargar M; Taghvaye Masoumi H; Amini S; Vaezi M; Hadjibabaie M; Mohammadi M; Sadeghi K
J Oncol Pharm Pract; 2023 Jul; 29(5):1112-1118. PubMed ID: 35392730
[TBL] [Abstract][Full Text] [Related]
20. Bloodstream infection by multidrug-resistant Streptococcus oralis in a leukemic patient with febrile neutropenia after hematopoietic stem cell transplantation.
Watanabe N; Kobayashi K; Koyama S; Tabira M; Matsuno J; Taji Y; Akuzawa Y; Ishikawa M; Maeda T; Imai K; Tarumoto N; Asou N; Mitsutake K; Ebihara Y
Transpl Infect Dis; 2020 Apr; 22(2):e13246. PubMed ID: 31943573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
